Particle.news
Download on the App Store

Ben Sasse’s Candid Cancer Interview Moves NYT Host, Draws Wide Praise

Sasse credits Christian faith for calm during experimental therapy with severe side effects.

Overview

  • Sasse’s conversation on a New York Times podcast spread widely this week after host Ross Douthat teared up at his steady talk about death.
  • Sasse said he was diagnosed in December with Stage IV pancreatic cancer that doctors deemed inoperable with only months to live.
  • He said he is in a clinical trial at M.D. Anderson using an experimental drug that triggers bleeding, peeling, and rashes.
  • Sasse said his belief in the Resurrection gave him peace about dying and removed much of his fear.
  • He voiced worry about leaving his children without a father, noting a teenage son and two adult daughters.